A chemical perspective on the clinical use of platinum-based anticancer drugs-Reference-Cited by-同舟云学术

A chemical perspective on the clinical use of platinum-based anticancer drugs

Published:2022 Issue:29 Volume:51 Page:10835-10846
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Alassadi Shoohb¹^ORCID,Pisani Michelle J.²^ORCID,Wheate Nial J.¹^ORCID

Affiliation:

1. School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia

2. East Hills Boys High School, Lucas Road, Panania, NSW, 2213, Australia

Abstract

Chemists have a key role to play in the clinical use and improvement of platinum anticancer drugs with regard to preclinical testing, formulation, pharmacokinetics, and drug–drug interactions.

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/DT/D2DT01875F

Reference99 articles.

1. Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery

2. Carboplatin: A clinical review

3. Oxaliplatin: a review of approved uses

4. Drugs in R&D , 2003 , 4 , 369–372

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serial triphenylpropionic acid and N,N'-chelator mixed ligands Cu(II) complexes: Structure and biological properties;Journal of Molecular Structure;2025-02

2. Recent development of Schiff-base metal complexes as therapeutic agents for lung cancer;Journal of Molecular Structure;2024-12

3. A series of DNA targeted Cu (II) complexes containing 1,8-naphthalimide ligands: Synthesis, characterization and in vitro anticancer activity;Journal of Inorganic Biochemistry;2024-12

4. Co-targeting CDK 4/6 and C-MYC/STAT3/CCND1 axis and inhibition of tumorigenesis and epithelial-mesenchymal-transition in triple negative breast cancer by Pt(II) complexes bearing NH3 as trans-co-ligand;Journal of Inorganic Biochemistry;2024-10

5. Advancements in platinum-based anticancer drug development: A comprehensive review of strategies, discoveries, and future perspectives;Bioorganic & Medicinal Chemistry;2024-10